A group of researchers at Harvard Medical School has found that medical industry payments to physicians in Massachusetts are associated with higher rates of prescribing brand-name drugs that treat high cholesterol. The study’s finding, published today in JAMA Internal Medicine, is in line with aProPublica analysis and story from March, which
Another Study Finds Link Between Pharma Money And Brand-Name Prescribing
The findings, by researchers at Harvard Medical School, are in line with a similar analysis done by ProPublica in March.
